Opportunity Information: Apply for PAS 17 026
The NIH funding opportunity "Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R03)" (Funding Opportunity Number PAS-17-026) is a small research grant program focused on strengthening what is known about end-of-life care for people living with Alzheimers disease and related dementias (ADRD), as well as the experiences and needs of their families and caregivers. The central aim is to close important clinical and translational gaps, meaning the program is looking for research that can more directly inform real-world care decisions, service delivery, and policies affecting patients with ADRD near the end of life. Rather than funding new, large-scale data collection, this announcement is specifically oriented toward well-designed studies that make strong use of data that already exist.
A defining feature of the opportunity is its emphasis on secondary data analysis. Applicants are invited to use existing datasets to examine end-of-life care needs, patterns of care, quality outcomes, and factors that shape quality of life for individuals with ADRD in the final stage of illness. The FOA particularly encourages secondary analysis of data from longitudinal cohort studies (datasets that follow individuals over time, which can help clarify trajectories of decline, care transitions, and timing of interventions) and from administrative records (such as claims, health system records, or other service-use datasets that can reveal utilization patterns, costs, and the impact of care settings). In practical terms, this mechanism is best suited for projects that can answer focused questions using established datasets, produce findings relatively quickly, and provide evidence that can be translated into improvements in care quality and patient and caregiver outcomes.
This opportunity is offered as a discretionary grant under the NIH R03 mechanism, which is designed for smaller, targeted research projects. The listed award ceiling is $50,000, reflecting the smaller scale typical of R03 awards and the expectation that the project scope is feasible without extensive new infrastructure or large primary data collection. The funding activity category is listed under Education and Health, and the associated CFDA numbers are 93.361 and 93.866, indicating alignment with NIH programs that include aging-related and neurological or dementia-related research priorities.
Eligibility is broad and includes a wide range of public, private, and nonprofit entities. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations other than small businesses; small businesses; and other eligible entities. The FOA also explicitly highlights additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). Taken together, this reflects a clear intent to encourage diverse institutional participation and to support research that may be grounded in a variety of communities, care systems, and service contexts.
Administratively, the agency is the National Institutes of Health, and the opportunity was created on 2016-10-21, with an original closing date listed as 2020-01-07. While those dates suggest the specific cycle referenced here has closed, the summary still captures what the FOA was designed to support: careful, impactful analyses of existing longitudinal or administrative datasets to improve end-of-life care for people with ADRD and to better support families during a period that often involves complex symptoms, difficult care transitions, and high caregiver burden.Apply for PAS 17 026
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361, 93.866.
- This funding opportunity was created on 2016-10-21.
- Applicants must submit their applications by 2020-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $50,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the funding opportunity PAS-17-026 about?
PAS-17-026, titled "Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R03)," is an NIH small research grant opportunity focused on strengthening evidence about end-of-life care for people living with Alzheimers disease and related dementias (ADRD), as well as the experiences and needs of their families and caregivers.
What is the main goal of this FOA?
The central goal is to close key clinical and translational gaps by supporting research that can more directly inform real-world care decisions, service delivery approaches, and policies affecting individuals with ADRD near the end of life.
What kind of research does this opportunity prioritize?
This FOA prioritizes well-designed studies that use existing data to examine end-of-life care needs, patterns of care, quality outcomes, and factors that influence quality of life for individuals with ADRD in the final stage of illness.
Is this program intended for new data collection?
No. A defining feature of this opportunity is its emphasis on secondary data analysis rather than new, large-scale primary data collection.
What does "secondary data analysis" mean in this context?
Secondary data analysis means using datasets that already exist (rather than collecting new data) to answer specific research questions related to end-of-life care and outcomes for people with ADRD.
What types of existing datasets are especially encouraged?
The FOA particularly encourages secondary analysis using (1) longitudinal cohort study data (which follow people over time) and (2) administrative records, such as claims or health system/service-use data.
Why are longitudinal cohort datasets relevant for this topic?
Longitudinal cohort datasets can help clarify trajectories of decline, care transitions, and the timing of interventions across the course of illness, which is often critical to understanding end-of-life experiences in ADRD.
Why are administrative datasets relevant for this topic?
Administrative datasets (such as claims or health system records) can reveal utilization patterns, costs, and the influence of care settings, offering insights into how services are delivered near the end of life.
What outcomes or topics could be examined under this FOA?
Based on the description, projects may examine end-of-life care needs, patterns of care, quality outcomes, and factors shaping quality of life for individuals with ADRD, along with the experiences and needs of families and caregivers.
What is the grant mechanism used for this funding opportunity?
This opportunity uses the NIH R03 mechanism, which is designed for smaller, targeted research projects.
What is the maximum award amount mentioned for this R03 opportunity?
The listed award ceiling is $50,000, consistent with the smaller scope typical of R03 awards.
What is the expected project scope given the R03 mechanism and budget ceiling?
The opportunity is best suited for focused projects that can leverage established datasets, answer targeted questions, produce findings relatively quickly, and generate evidence that can be translated into improvements in care quality and patient and caregiver outcomes.
Which federal agency is offering this opportunity?
The funding opportunity is offered by the National Institutes of Health (NIH).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is PAS-17-026.
What is the CFDA information associated with this opportunity?
The associated CFDA numbers listed are 93.361 and 93.866, indicating alignment with NIH programs that include aging-related and neurological or dementia-related research priorities.
What is the funding activity category for this opportunity?
The funding activity category is listed under Education and Health.
Who is eligible to apply?
Eligibility is broad and includes many public, private, nonprofit, and for-profit entities, as well as small businesses and other eligible entities.
Are government entities eligible to apply?
Yes. Eligible government applicants include state, county, city or township, and special district governments.
Are educational institutions eligible to apply?
Yes. Eligible applicants include independent school districts; public and state-controlled institutions of higher education; and private institutions of higher education.
Are tribal governments and tribal organizations eligible to apply?
Yes. Eligibility includes federally recognized Native American tribal governments and tribal organizations that are not federally recognized.
Are housing authorities eligible to apply?
Yes. Public housing authorities and Indian housing authorities are listed among eligible applicants.
Are nonprofits eligible to apply, including those without 501(c)(3) status?
Yes. Nonprofits with or without 501(c)(3) status are eligible.
Are for-profit organizations eligible to apply?
Yes. For-profit organizations other than small businesses are listed as eligible, and small businesses are also eligible.
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly highlights faith-based or community-based organizations among additional eligible applicant categories.
Are minority-serving institutions specifically encouraged or included as eligible?
Yes. The FOA explicitly highlights several categories, including Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).
Are U.S. territories or possessions eligible to apply?
Yes. U.S. territories or possessions are included among the additional eligible applicant categories.
Are non-U.S. (foreign) organizations eligible to apply?
Yes. Non-U.S. entities (foreign organizations) are explicitly included in the eligibility description.
Does this FOA emphasize producing results that can influence real-world care?
Yes. The announcement emphasizes clinical and translational relevance, meaning the research should help inform care decisions, service delivery, and policies affecting people with ADRD near the end of life.
What does the FOA suggest about timelines and speed of results?
Because the FOA is oriented toward secondary data analysis using established datasets, it is described as well suited for projects that can produce findings relatively quickly compared to studies requiring new large-scale data collection.
When was this opportunity created and what was the listed closing date?
The opportunity was created on 2016-10-21, and the original closing date listed is 2020-01-07.
Is this specific opportunity cycle still open based on the dates provided?
Based on the provided closing date (2020-01-07), the specific cycle referenced appears to be closed.
What patient population is the focus of this FOA?
The focus is on persons with Alzheimers disease and related dementias (ADRD), specifically in the end-of-life stage.
Does the FOA include a focus on families and caregivers?
Yes. The FOA highlights the experiences and needs of families and caregivers, recognizing issues such as complex symptoms, difficult care transitions, and high caregiver burden near the end of life.
Browse more opportunities from the same category: Education, Health
Next opportunity: Inclusive Education for Learners with Disabilities
Previous opportunity: Limited Competition: Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study (U01)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAS 17 026
Applicants also applied for:
Applicants who have applied for this opportunity (PAS 17 026) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCI Research Specialist (Core-based Scientist) Award (R50) Apply for PAR 17 050 Funding Number: PAR 17 050 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Research Specialist (laboratory-based Scientist) Award (R50) Apply for PAR 17 049 Funding Number: PAR 17 049 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Phylodynamic Tracking of HIV Transmission (R01) Apply for PAR 17 048 Funding Number: PAR 17 048 Agency: National Institutes of Health Category: Education, Health Funding Amount: $499,999 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21) Apply for RFA CA 17 010 Funding Number: RFA CA 17 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| National Cancer Institute Youth Enjoy Science Research Education Program (R25) Apply for PAR 17 059 Funding Number: PAR 17 059 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Promoting Caregiver Health Using Self-Management (R01) Apply for PA 17 062 Funding Number: PA 17 062 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1) Apply for RFA CA 16 501 Funding Number: RFA CA 16 501 Agency: National Institutes of Health Category: Education, Health Funding Amount: $3,000,000 |
| Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21) Apply for PA 17 061 Funding Number: PA 17 061 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01) Apply for PA 17 060 Funding Number: PA 17 060 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Transition Career Development Award to Promote Diversity (K22) Apply for PAR 17 069 Funding Number: PAR 17 069 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Optimizing the HIV Care Continuum for Substance Abusing Populations at High-Risk and/or Living with HIV (R01) Apply for RFA DA 17 024 Funding Number: RFA DA 17 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) Apply for RFA CA 17 014 Funding Number: RFA CA 17 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Awards to Institutional Training Programs to Advance Research on Alzheimers Disease and Alzheimer's Disease Related Dementias (T32) Apply for PAR 17 072 Funding Number: PAR 17 072 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01) Apply for PA 17 073 Funding Number: PA 17 073 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NIH-DoD-VA Pain Management Collaboratory - Coordinating Center (U24) Apply for RFA AT 17 002 Funding Number: RFA AT 17 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Tobacco Use and HIV in Low and Middle Income Countries (R01) Apply for PAR 17 087 Funding Number: PAR 17 087 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Tobacco Use and HIV in Low and Middle Income Countries (R21) Apply for PAR 17 086 Funding Number: PAR 17 086 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| NLM Administrative Supplements for Informationist Services in NIH-funded Research Projects (Admin Supp) Apply for PA 17 090 Funding Number: PA 17 090 Agency: National Institutes of Health Category: Education, Health Funding Amount: $25,000 |
| Cancer Immune Monitoring and Analysis Centers (U24) Apply for RFA CA 17 005 Funding Number: RFA CA 17 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,400,000 |
| Cancer Immunologic Data Commons (CIDC) (U24) Apply for RFA CA 17 006 Funding Number: RFA CA 17 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: $900,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAS 17 026", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.